Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Breast Neoplasms 1

Interventions

Metformin 139Clomiphene 44Letrozole 36Inositol 28Folic Acid 17Exercise 17Progesterone 16Ethinyl Estradiol 13Caloric Restriction 13drospirenone and ethinyl estradiol combination 12Estradiol 12Contraceptives, Oral 11cetrorelix 10Pioglitazone 10High-Intensity Interval Training 10Chorionic Gonadotropin 10Triptorelin Pamoate 9Tablets 9Spironolactone 8Diet 8Cholecalciferol 8Vitamin D 7Thioctic Acid 7Surveys and Questionnaires 7Menotropins 7Liraglutide 7Gonadotropins 7Acupuncture Therapy 7drospirenone 6Ovidrel 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Polycystic Ovary Syndrome × Parabens × Clear all
NCT06968455 2025-05-13

Endocrine Disruptors, Toxic and Essential Chemical Elements and Polycystic Ovary Syndrome

University Medical Centre Ljubljana

Completed
70 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡